Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine effects on coronary plaque burden and composition in coronary artery disease
2012-004779-38Phase 3Terminated
- Sponsor
- Servier
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Ivabradine with Placebo (2 arms). Primary endpoint: Nominal change in coronary percent atheroma volume. Started Feb 2013; status: terminated.
02
Drugs
ivabradine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2012-004779-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004779-38.